Lymphoepithelial Carcinoma

histology

Identifier: CI-CAN-00003125
Entity page: /cancer/lymphoepithelial-carcinoma ↗
Edges: 52

Neighbours: 22 drugs10 trials
Drawn: 32 of 32 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Lymphoepithelial Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived22 of 22show fewer
→ investigated in trials for	Bevacizumabmonoclonal antibody 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphoepithelial Carcinoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Cisplatinsmall molecule

Lymphoepithelial Carcinoma studied in …STUDIED_INderived10 of 30show all (up to 200)
→ studied in	NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 30 trials mapped (5 active)	—	—	Invasive Bladder Lymphoepithelioma-Like Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06568172Phase 3 · suspended Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer · condition mapped CURATED_BROADER · 30 trials mapped (5 active)	—	—	Skin Lymphoepithelial Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00336063Phase 1 · active not recruiting Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma · condition mapped CURATED_BROADER · 30 trials mapped (5 active)	—	—	Nasopharyngeal Undifferentiated Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 30 trials mapped (5 active)	—	—	Nasopharyngeal Undifferentiated Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07584499Phase 1 · recruiting Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 30 trials mapped (5 active)	—	—	Lymphoepithelial Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04458909Phase 3 · terminated Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer · condition mapped CURATED_BROADER · 30 trials mapped (5 active)	—	—	Nasopharyngeal Undifferentiated Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06969534Phase 2 · recruiting Safety and Efficacy of Pucotenlimab in pLECC · condition mapped ALIAS · 30 trials mapped (5 active)	—	—	Lymphoepithelial Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01956084Phase 1 · completed Cytotoxic T Cells to Treat Relapsed EBV-positive Lymphoma · condition mapped ALIAS · 30 trials mapped (5 active)	—	—	Lymphoepithelial Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00274937Phase 3 · completed Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer · condition mapped CURATED_BROADER · 30 trials mapped (5 active)	—	—	Nasopharyngeal Undifferentiated Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00470496Phase 1 · completed Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer · condition mapped CURATED_BROADER · 30 trials mapped (5 active)	—	—	Nasopharyngeal Undifferentiated Carcinoma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains